Additional file 1 of The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study

Additional file 1: Table S1. Number of subjects screened/excluded/included and reason for exclusion. Figure S1. Venn diagram showing variations in self-reported improvement in health status. Table S2. Univariate analysis of various clinical and laboratory parameters vs treatment success. Table S3. Rates of Adverse Events (AE)/Serious Adverse Event (SAE) among patients treated with pivmecillinam 400 mg QID for 1 week (ITT, n = 53).